Looks like the 2020 AAAAi is optimum for bcx7353:
This year’s theme, ‘New Paradigms in the Management of Allergic Diseases – Focus on Biologics’, acknowledges that there has been tremendous growth in the availability of biologic agents to treat many types of allergic disease. This growth has created many questions about how to choose which biologic agent will likely be best for individual patients, how they can best be combined with other therapies and how to maximize benefits and minimize adverse effects of these important and powerful new agents.”
The Use of Biologic Therapies for the Treatment of Hereditary Angioedema (HAE)
Biologic therapies are still a new option for the treatment of patients with HAE, and many providers report unfamiliarity with the appropriate use of these new treatments. This seminar will prepare physicians and other healthcare providers to incorporate the use of biologics into their care of HAE patients by reviewing the efficacy and safety data for these therapeutics, as well as the qualities of patients best suited to receive them.
Summarize the efficacy data for using biologic therapy for the treatment of HAE
Outline the safety data for using biologic therapy for the treatment of HAE
List the patient clinical characteristics and biomarker features that would lead to the use of biologic therapy for the treatment of HAE